Healthcare careers for chemists are once again largely based in laboratories, although increasingly there is opportunity to work at the point of care, helping with patient investigation. In a patent, 26364-65-8, name is 2-Cyanoimino-1,3-thiazolidine, introducing its new discovery. Related Products of 26364-65-8
An antibiotic anticancer active compound preparation method, comprising: cooling the ice, compound HRB-1365-0 : C4H6N2 S2, compound HRB-1365-1 : C2H7NS, and water, stirring reaction in alkaline conditions, filtration to obtain white solid, that is, for the compound HRB-1365-2 : C4H5N3S; under ice cooling, compound HRB-1365-2 : C4H5N3S, compound HRB-1365-1 : C2H7NS, triethylamine, stirring reaction in the methanol, after the completion of reaction, methanol concentrated under reduced pressure, the residue is washed with water, filtered, to obtain yellow solid is the compound HRB-1365: C6H9N3 S2; compound HRB-1365: C6H9N3 S2 of ethanol solution under stirring in the ice bath to cool down, to the drying to obtain the hydrogen chloride gas is introduced, after the saturation, continuing to stir, filtering and drying the obtained product. (by machine translation)
In the meantime we’ve collected together some recent articles in this area about 26364-65-8 to whet your appetite. Happy reading!
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H621N | ChemSpider